Paper138294
[Organ specific application of drugs by means of cellular capsule systems (author's transl)].
Zimmermann U and 1 other. Z Naturforsch C Biosci, 1976. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. [Organ specific application of drugs by means of cellular capsule systems (author's transl)]. Papers, record 138294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/138294
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Organ specific application of drugs by means of cellular capsule systems (author's transl)].
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Methotrexate | Major topic |
| Animals | |
| Cell Membrane Permeability | |
| Kinetics | |
| Liver | |
| Mice | |
| Organ Specificity | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33946445 | Chitosan Functionalized Magnetic Nanoparticles to Provide Neural Regeneration and Recovery after Experimental Model Induced Peripheral Nerve Injury. | Biomolecules | 2021 | https://conductscience.org/library/papers/33946445 | PubMed |
| 32587771 | Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer. | Cancer Biol Med | 2020 | https://conductscience.org/library/papers/32587771 | PubMed |
| 29930730 | Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. | Theranostics | 2018 | https://conductscience.org/library/papers/29930730 | PubMed |
| 25377422 | Open challenges in magnetic drug targeting. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2015 | https://conductscience.org/library/papers/25377422 | PubMed |
| 21278859 | The Behaviors of Ferro-Magnetic Nano-Particles In and Around Blood Vessels under Applied Magnetic Fields. | J Magn Magn Mater | 2011 | https://conductscience.org/library/papers/21278859 | PubMed |
| 19591456 | Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation. | Mol Pharm | 2009 | https://conductscience.org/library/papers/19591456 | PubMed |
| 6478060 | Stomatocytosis of latex particles (0.26 micron) by rat erythrocytes by the electrical breakdown technique. | Blut | 1984 | https://conductscience.org/library/papers/6478060 | PubMed |
| 480336 | Reversible electrical breakdown of lipid bilayer membranes: a charge-pulse relaxation study. | J Membr Biol | 1979 | https://conductscience.org/library/papers/480336 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/138294
GET https://conductscience.org/api/papers/v1/138294/authors